Verastem (VSTM) Common Equity (2018 - 2025)
Historic Common Equity for Verastem (VSTM) over the last 8 years, with Q3 2025 value amounting to -$15.5 million.
- Verastem's Common Equity fell 24037.97% to -$15.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$15.5 million, marking a year-over-year decrease of 24037.97%. This contributed to the annual value of -$28.9 million for FY2024, which is N/A changed from last year.
- Verastem's Common Equity amounted to -$15.5 million in Q3 2025, which was down 24037.97% from $36.1 million recorded in Q2 2025.
- Over the past 5 years, Verastem's Common Equity peaked at $102.6 million during Q1 2021, and registered a low of -$32.4 million during Q1 2025.
- Its 5-year average for Common Equity is $46.8 million, with a median of $50.6 million in 2022.
- Over the last 5 years, Verastem's Common Equity had its largest YoY gain of 9126.84% in 2025, and its largest YoY loss of 24037.97% in 2025.
- Quarter analysis of 5 years shows Verastem's Common Equity stood at $87.6 million in 2021, then crashed by 45.88% to $47.4 million in 2022, then soared by 75.52% to $83.2 million in 2023, then crashed by 134.74% to -$28.9 million in 2024, then surged by 46.26% to -$15.5 million in 2025.
- Its Common Equity was -$15.5 million in Q3 2025, compared to $36.1 million in Q2 2025 and -$32.4 million in Q1 2025.